Sensus Healthcare Stock Price, News & Analysis (NASDAQ:SRTS)

$5.67 +0.01 (+0.18 %)
(As of 02/20/2018 01:02 AM ET)
Previous Close$5.66
Today's Range$5.65 - $5.74
52-Week Range$3.38 - $6.25
Volume1,700 shs
Average Volume8,970 shs
Market Capitalization$76.76 million
P/E Ratio-20.25
Dividend YieldN/A
Beta-1.79

About Sensus Healthcare (NASDAQ:SRTS)

Sensus Healthcare, Inc., formerly Sensus Healthcare, LLC, is a manufacturer of superficial radiation therapy devices. The Company designs, manufactures and markets medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The superficial radiation therapy is an alternative to surgical basal cell carcinoma treatment and squamous cell carcinoma treatment. The Company's product, the SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions, such as keloids. The SRT-100 treats primary lesions that would otherwise be difficult or require surgery involving sensitive areas of the head and neck regions, such as the fold in the nose, eyelids, lips, corner of the mouth and the lining of the ear.

Receive SRTS News and Ratings via Email

Sign-up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Diagnostic & Testing Equipment
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:SRTS
CUSIPN/A
Phone561-922-5808

Debt

Debt-to-Equity Ratio0.19%
Current Ratio3.68%
Quick Ratio3.44%

Price-To-Earnings

Trailing P/E Ratio-20.2492768115424
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$20.59 million
Price / Sales3.73
Cash FlowN/A
Price / CashN/A
Book Value$0.87 per share
Price / Book6.52

Profitability

Trailing EPS($0.28)
Net Income$-3,710,000.00
Net Margins-18.02%
Return on Equity-29.60%
Return on Assets-19.83%

Miscellaneous

Employees37
Outstanding Shares13,540,000

Sensus Healthcare (NASDAQ:SRTS) Frequently Asked Questions

What is Sensus Healthcare's stock symbol?

Sensus Healthcare trades on the NASDAQ under the ticker symbol "SRTS."

How were Sensus Healthcare's earnings last quarter?

Sensus Healthcare Inc (NASDAQ:SRTS) posted its earnings results on Thursday, February, 2nd. The company reported ($0.02) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.03) by $0.01. The company earned $4.88 million during the quarter, compared to analysts' expectations of $4.18 million. Sensus Healthcare had a negative net margin of 18.02% and a negative return on equity of 29.60%. View Sensus Healthcare's Earnings History.

Where is Sensus Healthcare's stock going? Where will Sensus Healthcare's stock price be in 2018?

1 brokers have issued 12 month price targets for Sensus Healthcare's stock. Their predictions range from $9.00 to $9.00. On average, they expect Sensus Healthcare's stock price to reach $9.00 in the next year. View Analyst Ratings for Sensus Healthcare.

Who are some of Sensus Healthcare's key competitors?

Who are Sensus Healthcare's key executives?

Sensus Healthcare's management team includes the folowing people:

  • Joseph C. Sardano, Chairman of the Board, Chief Executive Officer (Age 63)
  • Kalman Fishman, Co-Founder, Chief Operating Officer, Chief Technology Officer (Age 45)
  • Richard Golin, Co-Founder, Executive Vice President - Sales, Oncology and International (Age 62)
  • Arthur R. Levine, Chief Financial Officer (Age 58)
  • Stephen Brad Cohen, Senior Vice President - Strategic Initiatives and Dermatology (Age 56)
  • Anthony B. Petrelli, Director (Age 65)
  • John P. Heinrich Ph.D., Non-Executive Independent Director (Age 68)
  • William McCall, Non-Executive Independent Director (Age 69)
  • Samuel O'Rear, Non-Executive Independent Director (Age 67)

When did Sensus Healthcare IPO?

(SRTS) raised $20 million in an initial public offering (IPO) on Wednesday, March 30th 2016. The company issued 1,800,000 shares at $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company acted as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager.

Who owns Sensus Healthcare stock?

Sensus Healthcare's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Millennium Management LLC (0.42%). Company insiders that own Sensus Healthcare stock include Arthur Levine, Joseph C Sardano, Kalman Fishman, Richard Golin and Stephen Brad Cohen. View Institutional Ownership Trends for Sensus Healthcare.

Who sold Sensus Healthcare stock? Who is selling Sensus Healthcare stock?

Sensus Healthcare's stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC. Company insiders that have sold Sensus Healthcare company stock in the last year include Arthur Levine, Joseph C Sardano, Kalman Fishman, Richard Golin and Stephen Brad Cohen. View Insider Buying and Selling for Sensus Healthcare.

How do I buy Sensus Healthcare stock?

Shares of Sensus Healthcare can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sensus Healthcare's stock price today?

One share of Sensus Healthcare stock can currently be purchased for approximately $5.67.

How big of a company is Sensus Healthcare?

Sensus Healthcare has a market capitalization of $76.76 million and generates $20.59 million in revenue each year. The company earns $-3,710,000.00 in net income (profit) each year or ($0.28) on an earnings per share basis. Sensus Healthcare employs 37 workers across the globe.

How can I contact Sensus Healthcare?

Sensus Healthcare's mailing address is 851 BROKEN SOUND PKWY. NW SUITE 215, BOCA RATON FL, 33487. The company can be reached via phone at 561-922-5808 or via email at [email protected]


MarketBeat Community Rating for Sensus Healthcare (SRTS)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  47 (Vote Outperform)
Underperform Votes:  49 (Vote Underperform)
Total Votes:  96
MarketBeat's community ratings are surveys of what our community members think about Sensus Healthcare and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Sensus Healthcare (NASDAQ:SRTS) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $9.00$7.50$7.50$6.50
Price Target Upside: 63.64% upside28.21% upside28.21% upside62.50% upside

Sensus Healthcare (NASDAQ:SRTS) Consensus Price Target History

Price Target History for Sensus Healthcare (NASDAQ:SRTS)

Sensus Healthcare (NASDAQ:SRTS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/2/2018Maxim GroupBoost Price TargetBuy -> Buy$7.50 -> $9.00MediumView Rating Details
8/8/2016Northland SecuritiesReiterated RatingOutperform$8.00N/AView Rating Details
(Data available from 2/20/2016 forward)

Earnings

Sensus Healthcare (NASDAQ:SRTS) Earnings History and Estimates Chart

Earnings by Quarter for Sensus Healthcare (NASDAQ:SRTS)

Sensus Healthcare (NASDAQ SRTS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2017Q3 2017($0.07)($0.07)ViewN/AView Earnings Details
8/3/2017Q2 2017($0.14)($0.06)$4.50 million$4.97 millionViewListenView Earnings Details
5/4/2017Q1 2017($0.12)$4.25 million$4.35 millionViewListenView Earnings Details
2/2/2017Q416($0.03)($0.02)$4.18 million$4.88 millionViewListenView Earnings Details
8/4/2016Q2 2016($0.03)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Sensus Healthcare (NASDAQ:SRTS) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.08 EPS

Dividends

Dividend History for Sensus Healthcare (NASDAQ:SRTS)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Sensus Healthcare (NASDAQ SRTS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 41.70%
Institutional Ownership Percentage: 6.21%
Insider Trades by Quarter for Sensus Healthcare (NASDAQ:SRTS)
Institutional Ownership by Quarter for Sensus Healthcare (NASDAQ:SRTS)

Sensus Healthcare (NASDAQ SRTS) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/27/2017Arthur LevineCFOSell217$6.00$1,302.00216,793View SEC Filing  
10/27/2017Joseph C SardanoCEOSell6,953$6.00$41,718.001,587,701View SEC Filing  
10/27/2017Kalman FishmanInsiderSell4,183$6.00$25,098.00960,649View SEC Filing  
9/12/2017Arthur LevineCFOSell381$6.00$2,286.00217,357View SEC Filing  
9/12/2017Joseph C SardanoCEOSell12,192$6.00$73,152.001,605,751View SEC Filing  
9/12/2017Richard GolinInsiderSell7,334$6.00$44,004.00971,509View SEC Filing  
9/6/2017Arthur LevineCFOSell417$6.00$2,502.00217,618View SEC Filing  
9/6/2017Joseph C SardanoCEOSell13,320$6.00$79,920.001,614,099View SEC Filing  
9/6/2017Kalman FishmanCTOSell2,250$6.00$13,500.00976,530View SEC Filing  
9/6/2017Richard GolinInsiderSell8,012$6.00$48,072.00976,530View SEC Filing  
9/5/2017Arthur LevineCFOSell300$6.00$1,800.00217,618View SEC Filing  
9/5/2017Joseph C SardanoCEOSell9,579$6.00$57,474.001,614,099View SEC Filing  
9/5/2017Kalman FishmanCTOSell5,762$6.00$34,572.00976,530View SEC Filing  
8/28/2017Arthur LevineCFOSell302$6.00$1,812.00217,985View SEC Filing  
8/28/2017Joseph C SardanoCEOSell9,625$6.00$57,750.001,625,821View SEC Filing  
8/28/2017Stephen Brad CohenInsiderSell3,908$6.00$23,448.00983,583View SEC Filing  
8/24/2017Arthur LevineCFOSell271$6.00$1,626.00218,220View SEC Filing  
8/24/2017Joseph C SardanoCEOSell8,167$6.00$49,002.001,637,891View SEC Filing  
8/24/2017Kalman FishmanInsiderSell5,378$6.00$32,268.00990,845View SEC Filing  
12/2/2016Joseph C SardanoCEOSell274$6.00$1,644.001,641,636View SEC Filing  
12/2/2016Richard GolinInsiderSell187$6.00$1,122.00993,586View SEC Filing  
11/30/2016Joseph C SardanoCEOSell924$6.00$5,544.001,642,264View SEC Filing  
11/30/2016Stephen Brad CohenInsiderSell679$6.00$4,074.00994,032View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Sensus Healthcare (NASDAQ SRTS) News Headlines

Source:
DateHeadline
Sensus Healthcare Inc (SRTSU) Files 10-K for the Fiscal Year Ended on December 31, 2017Sensus Healthcare Inc (SRTSU) Files 10-K for the Fiscal Year Ended on December 31, 2017
finance.yahoo.com - February 16 at 9:18 AM
Sensus Healthcare Opens Tel Aviv Office to Expand Footprint in Israel, the Middle East & EuropeSensus Healthcare Opens Tel Aviv Office to Expand Footprint in Israel, the Middle East & Europe
finance.yahoo.com - February 7 at 9:03 AM
Blog Exposure - Teleflex Announces Launch of Expro Elite(TM) and Sympro Elite(TM) Snares for Peripheral Procedures in the USBlog Exposure - Teleflex Announces Launch of Expro Elite(TM) and Sympro Elite(TM) Snares for Peripheral Procedures in the US
finance.yahoo.com - February 7 at 9:03 AM
Active-Investors: Free Research Report as Hill-Roms Revenue Rose 5% and Adjusted EPS Surged 23%Active-Investors: Free Research Report as Hill-Rom's Revenue Rose 5% and Adjusted EPS Surged 23%
www.finanznachrichten.de - February 6 at 4:33 PM
Sensus Healthcare Launches Collaboration with BirchBioMed to Treat and Prevent Scarring for Keloids Patients Around the WorldSensus Healthcare Launches Collaboration with BirchBioMed to Treat and Prevent Scarring for Keloids Patients Around the World
finance.yahoo.com - February 5 at 8:59 AM
Maxim Group Boosts Sensus Healthcare (SRTS) Price Target to $9.00Maxim Group Boosts Sensus Healthcare (SRTS) Price Target to $9.00
www.americanbankingnews.com - February 2 at 5:06 PM
Sensus Healthcare Reports Record Revenue for 2017 Fourth Quarter and Full YearSensus Healthcare Reports Record Revenue for 2017 Fourth Quarter and Full Year
finance.yahoo.com - February 1 at 4:35 PM
Sensus Healthcare, Inc. to Host Earnings CallSensus Healthcare, Inc. to Host Earnings Call
finance.yahoo.com - February 1 at 4:35 PM
Sensus Healthcare (SRTS) Downgraded by TheStreetSensus Healthcare (SRTS) Downgraded by TheStreet
www.americanbankingnews.com - January 30 at 7:32 AM
Sensus Healthcare to Host Fourth Quarter and Fiscal Year 2017 Financial Results and Business Update Conference Call on February 1, 2018Sensus Healthcare to Host Fourth Quarter and Fiscal Year 2017 Financial Results and Business Update Conference Call on February 1, 2018
finance.yahoo.com - January 25 at 8:59 AM
Sensus Healthcare Brings Superficial Radiation Therapy (SRT) to China for Keloid Prevention and TreatmentSensus Healthcare Brings Superficial Radiation Therapy (SRT) to China for Keloid Prevention and Treatment
www.bizjournals.com - January 8 at 9:36 AM
Sensus Healthcare, Inc. :SRTS-US: Earnings Analysis: Q3, 2017 By the Numbers : November 30, 2017Sensus Healthcare, Inc. :SRTS-US: Earnings Analysis: Q3, 2017 By the Numbers : November 30, 2017
finance.yahoo.com - November 30 at 11:25 AM
Sensus Healthcare to Present at the 10th Annual LD Micro Main EventSensus Healthcare to Present at the 10th Annual LD Micro Main Event
finance.yahoo.com - November 27 at 4:10 PM
Sensus Healthcare beats by $0.02, beats on revenueSensus Healthcare beats by $0.02, beats on revenue
seekingalpha.com - November 4 at 10:34 PM
Sensus Healthcare Reports Third Quarter Financial Results Featuring Revenue up 44%Sensus Healthcare Reports Third Quarter Financial Results Featuring Revenue up 44%
finance.yahoo.com - November 4 at 5:28 PM
Edited Transcript of SRTS earnings conference call or presentation 2-Nov-17 8:30pm GMTEdited Transcript of SRTS earnings conference call or presentation 2-Nov-17 8:30pm GMT
finance.yahoo.com - November 4 at 5:28 PM
Sensus Healthcare, Inc. (SRTS) Price Target Raised to $7.50 at Maxim GroupSensus Healthcare, Inc. (SRTS) Price Target Raised to $7.50 at Maxim Group
www.americanbankingnews.com - November 3 at 8:52 AM
Sensus Healthcare Launches SRT-100 in China for Keloid Prevention and Treatment at Major Dermatology Conference, Extends Distribution Agreement with Chindex MedicalSensus Healthcare Launches SRT-100 in China for Keloid Prevention and Treatment at Major Dermatology Conference, Extends Distribution Agreement with Chindex Medical
finance.yahoo.com - November 1 at 9:09 AM
Sensus Healthcare, Inc. (SRTS) Insider Sells $25,098.00 in StockSensus Healthcare, Inc. (SRTS) Insider Sells $25,098.00 in Stock
www.americanbankingnews.com - October 31 at 2:51 PM
Insider Selling: Sensus Healthcare, Inc. (SRTS) CEO Sells 6,953 Shares of StockInsider Selling: Sensus Healthcare, Inc. (SRTS) CEO Sells 6,953 Shares of Stock
www.americanbankingnews.com - October 31 at 2:38 PM
Sensus Healthcare Announces Clearance to Market the SRT-100™ in MexicoSensus Healthcare Announces Clearance to Market the SRT-100™ in Mexico
finance.yahoo.com - October 31 at 9:58 AM
Sensus Healthcare to Host Third Quarter 2017 Financial Results and Business Update Conference Call on November 2, 2017Sensus Healthcare to Host Third Quarter 2017 Financial Results and Business Update Conference Call on November 2, 2017
finance.yahoo.com - October 25 at 11:10 AM
Stratpharma AG & Sensus Healthcare Announce Strategic Collaboration for Transformative Superficial Radiation Therapy & Post-Treatment CareStratpharma AG & Sensus Healthcare Announce Strategic Collaboration for Transformative Superficial Radiation Therapy & Post-Treatment Care
finance.yahoo.com - October 24 at 10:26 AM
Sensus Healthcare (SRTS) Presents At 3rd Annual Dawson James Small Cap Growth Conference 2017 - lideshowSensus Healthcare (SRTS) Presents At 3rd Annual Dawson James Small Cap Growth Conference 2017 - lideshow
seekingalpha.com - October 21 at 8:49 AM
Sensus Healthcare to Present at Dawson James Securities 3rd Annual Small Cap Growth ConferenceSensus Healthcare to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference
finance.yahoo.com - October 11 at 8:03 AM
Sensus Healthcare Announces Abstract on Treatment of Keloids with SRT at the 2017 American Society for Dermatologic Surgery Annual MeetingSensus Healthcare Announces Abstract on Treatment of Keloids with SRT at the 2017 American Society for Dermatologic Surgery Annual Meeting
finance.yahoo.com - October 10 at 7:06 AM
Sensus Healthcare Details Abstract on Keloid Treatment with SRT at the 2017 American Society for Dermatologic Surgery Annual MeetingSensus Healthcare Details Abstract on Keloid Treatment with SRT at the 2017 American Society for Dermatologic Surgery Annual Meeting
finance.yahoo.com - October 10 at 7:06 AM
Sensus Healthcare (SRTS) Presents At The Sidoti & Company Fall 2017 Convention - SlideshowSensus Healthcare (SRTS) Presents At The Sidoti & Company Fall 2017 Convention - Slideshow
seekingalpha.com - September 30 at 7:56 PM
Sensus Healthcare to Present at the Ladenburg Thalmann 2017 Healthcare ConferenceSensus Healthcare to Present at the Ladenburg Thalmann 2017 Healthcare Conference
finance.yahoo.com - September 20 at 9:25 AM
Sensus Healthcare, Inc. :SRTS-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017Sensus Healthcare, Inc. :SRTS-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
finance.yahoo.com - September 19 at 8:00 AM
Insider Selling: Sensus Healthcare, Inc. (SRTS) Insider Sells 7,334 Shares of StockInsider Selling: Sensus Healthcare, Inc. (SRTS) Insider Sells 7,334 Shares of Stock
www.americanbankingnews.com - September 13 at 4:36 PM
Sensus Healthcare, Inc. (SRTS) CEO Joseph C. Sardano Sells 12,192 SharesSensus Healthcare, Inc. (SRTS) CEO Joseph C. Sardano Sells 12,192 Shares
www.americanbankingnews.com - September 13 at 4:34 PM
Sensus Healthcare Cancels Presentation to Rodman & Renshaw Global Investment Conference due to Hurricane IrmaSensus Healthcare Cancels Presentation to Rodman & Renshaw Global Investment Conference due to Hurricane Irma
finance.yahoo.com - September 12 at 10:14 AM
Kalman Fishman Sells 5,762 Shares of Sensus Healthcare Inc (SRTS) StockKalman Fishman Sells 5,762 Shares of Sensus Healthcare Inc (SRTS) Stock
www.americanbankingnews.com - September 6 at 10:46 PM
Sensus Healthcare Inc (SRTS) CTO Sells $13,500.00 in StockSensus Healthcare Inc (SRTS) CTO Sells $13,500.00 in Stock
www.americanbankingnews.com - September 6 at 10:46 PM
Sensus Healthcare Inc (SRTS) Insider Richard Golin Sells 8,012 SharesSensus Healthcare Inc (SRTS) Insider Richard Golin Sells 8,012 Shares
www.americanbankingnews.com - September 6 at 10:26 PM
Sensus Healthcare Inc (SRTS) CEO Sells $57,474.00 in StockSensus Healthcare Inc (SRTS) CEO Sells $57,474.00 in Stock
www.americanbankingnews.com - September 6 at 10:26 PM
Joseph C. Sardano Sells 13,320 Shares of Sensus Healthcare Inc (SRTS) StockJoseph C. Sardano Sells 13,320 Shares of Sensus Healthcare Inc (SRTS) Stock
www.americanbankingnews.com - September 6 at 10:26 PM
Sensus Healthcare to Present at Upcoming Investor ConferencesSensus Healthcare to Present at Upcoming Investor Conferences
finance.yahoo.com - September 6 at 8:35 AM
Stephen Brad Cohen Sells 3,908 Shares of Sensus Healthcare, Inc. (SRTS) StockStephen Brad Cohen Sells 3,908 Shares of Sensus Healthcare, Inc. (SRTS) Stock
www.americanbankingnews.com - August 29 at 4:16 PM
Sensus Healthcare, Inc. (SRTS) CEO Sells $57,750.00 in StockSensus Healthcare, Inc. (SRTS) CEO Sells $57,750.00 in Stock
www.americanbankingnews.com - August 29 at 4:16 PM
Insider Selling: Sensus Healthcare, Inc. (SRTS) Insider Sells 5,378 Shares of StockInsider Selling: Sensus Healthcare, Inc. (SRTS) Insider Sells 5,378 Shares of Stock
www.americanbankingnews.com - August 25 at 4:32 PM
Joseph C. Sardano Sells 8,167 Shares of Sensus Healthcare, Inc. (SRTS) StockJoseph C. Sardano Sells 8,167 Shares of Sensus Healthcare, Inc. (SRTS) Stock
www.americanbankingnews.com - August 25 at 4:32 PM
Sensus Healthcare to Present at the 6th Annual Liolios Gateway Conference on September 6, 2017Sensus Healthcare to Present at the 6th Annual Liolios Gateway Conference on September 6, 2017
finance.yahoo.com - August 24 at 1:18 PM
Sensus Healthcare Offers Non-Surgical Option for Non-Melanoma Skin CancerSensus Healthcare Offers Non-Surgical Option for Non-Melanoma Skin Cancer
finance.yahoo.com - August 11 at 8:48 AM
Edited Transcript of SRTS earnings conference call or presentation 3-Aug-17 8:30pm GMTEdited Transcript of SRTS earnings conference call or presentation 3-Aug-17 8:30pm GMT
finance.yahoo.com - August 5 at 7:20 AM
Sensus Healthcare, Inc. (SRTS) Announces  Earnings Results, Beats Estimates By $0.08 EPSSensus Healthcare, Inc. (SRTS) Announces Earnings Results, Beats Estimates By $0.08 EPS
www.americanbankingnews.com - August 4 at 5:02 PM
Sensus Healthcare Reports Record Second Quarter Financial ResultsSensus Healthcare Reports Record Second Quarter Financial Results
finance.yahoo.com - August 4 at 8:34 AM
Sensus Healthcare (SRTS) Clearance to Sell SRT-100 in China for Treatment and Prevention of KeloidsSensus Healthcare (SRTS) Clearance to Sell SRT-100 in China for Treatment and Prevention of Keloids
www.streetinsider.com - July 28 at 8:20 AM
Corporate News Blog - Sensus Healthcare Announces Achievement of Approval from Chinas FDA for SRT-100, the Non-Invasive Superficial Radiation TherapyCorporate News Blog - Sensus Healthcare Announces Achievement of Approval from China's FDA for SRT-100, the Non-Invasive Superficial Radiation Therapy
finance.yahoo.com - July 28 at 8:20 AM

SEC Filings

Sensus Healthcare (NASDAQ:SRTS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Sensus Healthcare (NASDAQ:SRTS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Sensus Healthcare (NASDAQ SRTS) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.